Picture of DH Enchantment logo

ENMI DH Enchantment Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-1.07%
3m+191.8%
6m+295.58%
1yr+40.38%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-78.01%
50d MA+26.74%
200d MA-45.05%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Valuen/a
Price to Tang. Bookn/a
Price to Free Cashflown/a
Price to Sales34,915.02
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Margin-162280%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202531st Mar 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of DH Enchantment EPS forecast chart

Profile Summary

DH Enchantment, Inc. is a holding company. The Company conducts its operations through its Hong Kong subsidiary, Ho Shun Yi Limited (HSY). HSY is engaged primarily in the sale and distribution of COVID-19 rapid antigen tester sets. HSY is one of the authorized commercial distributors of the INDICAID COVID-19 Rapid Antigen Test in the Hong Kong market. The INDICAID COVID-19 Rapid Antigen Test is developed and manufactured in Hong Kong. The INDICAID product can provide a COVID-19 testing result in approximately 20 minutes. HSY’s main customers are distributors of personal hygiene products into the market.

Directors

    Last Annual
    March 31st, 2024
    Last Interim
    June 30th, 2024
    Incorporated
    July 9th, 2004
    Public Since
    October 29th, 2004
    No. of Shareholders
    69
    No. of Employees
    1
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    us flag iconPink Sheets on Nasdaq
    Shares in Issue
    831,310,013

    ENMI Share Price Performance

    Upcoming Events for ENMI

    Similar to ENMI

    Picture of Acusphere logo

    Acusphere

    us flag iconPink Sheets on Nasdaq

    Picture of Adorbs logo

    Adorbs

    us flag iconPink Sheets on Nasdaq

    Picture of Agentix logo

    Agentix

    us flag iconPink Sheets on Nasdaq

    Picture of Agrios Global Holdings logo

    Agrios Global Holdings

    us flag iconPink Sheets on Nasdaq

    Picture of Aida Pharmaceuticals logo

    Aida Pharmaceuticals

    us flag iconPink Sheets on Nasdaq

    FAQ